Medication info
Teddyform Extended-Release Tablet 20/1000 milligrams

Teddyform Extended-Release Tablet 20/1000 milligrams

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Pink oval-shaped extended-release film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201497 · Approved 2022.04.08 · Insurance code 645907300

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one tablet of this medication 20/1000mg extended-release tablet once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching from combination therapy with teneligliptin and metformin to this medication, the dose may be started at the existing doses of teneligliptin and metformin. When converting from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switching to it from other glucose-lowering medications. Since changes may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medication should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication helps improve blood sugar control in patients with type 2 diabetes by using Teneligliptin and Metformin together. When taken with dietary management and exercise therapy, it is effective for maintaining blood sugar levels. This facilitates better blood sugar management for patients, supporting diabetes management. Such combination therapy can stabilize blood sugar fluctuations and contribute to the prevention of complications. Therefore, this medication is used for the improvement of blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one tablet of this medication 20/1000mg extended-release tablet once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching from combination therapy with teneligliptin and metformin to this medication, the dose may be started at the existing doses of teneligliptin and metformin. When converting from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switching to it from other glucose-lowering medications. Since changes may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medication should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is used for the treatment of diabetes and helps lower blood sugar. However, there is a need for caution as very rarely serious side effects such as lactic acidosis can occur. Particularly, it is safer for patients with impaired kidney function, heart disease, or liver dysfunction not to use this medication. The use of this medication should be paused for a certain period before and after examinations using contrast agents, and it should only be resumed after confirming that kidney function is normal post-examination. Pregnant women or women capable of becoming pregnant, patients with severe infections or major trauma should also avoid this medication. When using this medication with other diabetes drugs, symptoms of hypoglycemia may appear, so blood sugar should be checked regularly and symptoms should be closely monitored. If symptoms of hypoglycemia occur, immediate action such as consuming foods containing sugar is necessary. This medication can affect liver and kidney function, so regular blood tests and kidney function tests should be conducted, with extra caution for the elderly. Alcohol consumption may increase the risk of lactic acidosis, so drinking should be avoided during treatment. In addition, this medication can lower vitamin B12 levels, so it is advisable to monitor blood levels regularly. In cases of surgery or significant illness that restrict food intake, this medication should also be temporarily discontinued. If during the course of this medication, sudden abdominal pain, vomiting, breathing difficulties, or weakness occurs, immediate consultation with a physician is necessary. Furthermore, if there are blisters or rashes on the skin, medication should be stopped immediately, and a specialist should be consulted. This medication is not recommended for children as its safety has not been established. Finally, while taking this medication, caution should be exercised for hypoglycemia or lactic acidosis symptoms when performing dangerous tasks such as driving or working at heights.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, bullous pemphigoid, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colon polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, elevated amylase, elevated lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), elevated serum potassium concentration, malaise, allergic rhinitis, elevated serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremors, headache, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, cold sweat, diabetic retinopathy, visual impairment, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophil count, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic encephalopathy, lumbar spinal canal stenosis, intervertebral disc herniation, intervertebral disc disorder, spinal ligament ossification, foraminal stenosis, rotator cuff syndrome, bladder mass, ureteral stone disease, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, dizziness, benign prostatic hyperplasia, knee surgery, urticaria, glaucoma, blurry vision, age-related macular degeneration, hyperthyroidism, primary hyperparathyroidism, angina, otalgia, iron deficiency anemia, food allergy, pressure ulcer, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, bruise, vomiting, abdominal pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, unusual weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, dyspnea, exertional dyspnea, atelectasis, epistaxis, chest discomfort, fever, chills, generalized edema, injection site inflammation, dysuria, kidney cyst, nocturia, anxiety disorder due to general medical condition, hearing loss, endolymphatic hydrops, increased serum creatinine, increased blood urea, atrial fibrillation, hypothyroidism, chronic bronchitis, non-thyroid hypertrophy, arteriosclerosis, hypertension, ovarian cyst, vulvar pruritus, menopausal symptoms, falls, animal bites, radial fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container that allows for good airflow, and the storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. Storing it this way will help maintain its effectiveness.

Appearance and packaging

Appearance

Pink oval-shaped extended-release film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.